‌

US Patent 9400280 Piperidine derivatives and methods of treating hepatitis B infections

Patent 9400280 was granted and assigned to Novira Therapeutics on July, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Novira Therapeutics

Current Assignee

Novira Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9400280

Date of Patent

July 26, 2016

Patent Application Number

14670001

Date Filed

March 26, 2015

Patent Primary Examiner

‌

David K O Dell

Patent abstract

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9400280 Piperidine derivatives and methods of treating hepatitis B infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API